Sponsored by AbbVie

Mindfulness-based cognitive therapy (MBCT)

By combining elements of cognitive behavioral therapy and mindfulness-based stress reduction, MBCT helps patients become more aware of their thoughts and emotions and how such thoughts and emotions may prolong depressive symptoms.1 MBCT aims to help patients reduce rumination on negative thoughts and increase their mindfulness and self-compassion.1 Treatment is structured and typically follows an 8-week course.2
Description: By combining elements of cognitive behavioral therapy and mindfulness-based stress reduction, MBCT helps patients become more aware of their thoughts and emotions and how such thoughts and emotions may prolong depressive symptoms.1 MBCT aims to help patients reduce rumination on negative thoughts and increase their mindfulness and self-compassion.1 Treatment is structured and typically follows an 8-week course.2
Potentially effective for the following mental health concerns: Depressive disorders
Potentially effective in the following age groups: Adolescent, Adult, Geriatric
Treatment setting options: Individual, Group
Treatment format options: In-person, Online
Typical treatment duration: < 10 sessions
Potential limitations: There are few formally trained MBCT practitioners, and this type of therapy may be difficult to access1

Footnotes:

Supporting references for the filters are as follows:
Potentially effective for the following mental health concerns: Depressive disorders1; Potentially effective in the following age groups: Adolescent3, Adult1, Geriatric4; Treatment setting options: Individual2, group1; Treatment format options: In-person5, Online6; Typical treatment duration: < 10 sessions2

References:

  1. MacKenzie, MB et al. Neuropsychiatr Dis Treat. 2018;14:1599-1605.
  2. Schroevers, MJ et al. Mindfulness (NY). 2016;7(6):1339-1346.
  3. Raj, S et al. Asian J Psychiatr. 2019;39:58-62.
  4. Labbe, M et al. Can Geriatr J. 2016;19(3):127-128.
  5. Hofmann, SG & Gomez, AF. Psychiatr Clin North Am. 2017;40(4):739-749.
  6. Segal, ZV et al. JAMA Psychiatry. 2020;77(6):563-573.

Welcome To NP Psych Navigator

This website is intended for healthcare professionals inside the United States.
Please confirm that you are a healthcare professional inside the US.

No, I am not US Healthcare professional

You are now leaving NP Psych Navigator

Links to sites outside of NP Psych Navigator are provided as a resource to the viewer. AbbVie Inc accepts no responsibility for the content of non-AbbVie linked sites.

Redirect to:

Please to bookmark content